Armata Pharmaceuticals

$ARMP is currently up over 15% and leading the Prism MarketView Pharmaceuticals Index. $ARMP has risen over the last month due to positive updates on its AP-PA02 and AP-SA02 studies

Share this article:

About the Author:

Armata Pharmaceuticals

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup